Literature DB >> 1891073

Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: putative role of basal forebrain target sites.

Z Sarnyai1, E Babarczy, M Kriván, G Szabó, G L Kovács, T Barth, G Telegdy.   

Abstract

The effects of oxytocin (OXT), arginine- and lysine-vasopressin (AVP and LVP) and an OXT-receptor antagonist on cocaine-induced sniffing behaviour were investigated in rats. OXT, but not AVP or LVP injected subcutaneously (s.c.) attenuated cocaine-induced sniffing. The effect of OXT (s.c.) was inhibited by an OXT-receptor antagonist administered intracerebroventricularly (i.c.v.). I.c.v. administration of different doses of OXT in nanogram quantities caused a dose-dependent attenuation of cocaine-induced sniffing. Local cerebral microinjection of OXT into the accumbens nucleus and olfactory tubercle but not into the olfactory nucleus, central amygdaloid nucleus or caudate nucleus, inhibited the cocaine-induced sniffing behaviour. These results demonstrate that OXT selectively attenuates the cocaine-induced stereotyped behaviour through basal forebrain target sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891073     DOI: 10.1016/0143-4179(91)90073-r

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  25 in total

Review 1.  Inhibitory role of oxytocin in psychostimulant-induced psychological dependence and its effects on dopaminergic and glutaminergic transmission.

Authors:  Jing-yu Yang; Jia Qi; Wen-yan Han; Fang Wang; Chun-fu Wu
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

2.  Intracranial self-stimulation of the paraventricular nucleus of the hypothalamus: increased faciliation by morphine compared to cocaine.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2012-05       Impact factor: 7.892

Review 3.  Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Authors:  Mary R Lee; Matthew C H Rohn; Gianluigi Tanda; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

Review 4.  Oxytocin for the treatment of drug and alcohol use disorders.

Authors:  Mary R Lee; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

5.  Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.

Authors:  Aurelien Bernheim; Kah-Chung Leong; Carole Berini; Carmela M Reichel
Journal:  Pharmacol Biochem Behav       Date:  2017-09-01       Impact factor: 3.533

6.  Attenuated cocaine-seeking after oxytocin administration in male and female rats.

Authors:  Amy S Kohtz; Belle Lin; Michael E Smith; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2018-04-18       Impact factor: 4.530

7.  Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study.

Authors:  Melissa A Miller; Anya Bershad; Andrea C King; Royce Lee; Harriet de Wit
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

8.  Gestational treatment with cocaine and fluoxetine alters oxytocin receptor number and binding affinity in lactating rat dams.

Authors:  Josephine M Johns; Deborah A Lubin; Cheryl H Walker; Paul Joyner; Christopher Middleton; Vivian Hofler; Matthew McMurray
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

Review 9.  The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.

Authors:  James P Burkett; Larry J Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

10.  Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice.

Authors:  Jia Qi; Jing-Yu Yang; Ming Song; Yan Li; Fang Wang; Chun-Fu Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.